Bukwang Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	437,578	373,446	314,207	417,573	598,978	883,065
Market Cap Growth	63.28%	18.85%	-24.75%	-30.29%	-32.17%	-54.11%
Enterprise Value	309,089	236,540	280,401	368,683	519,044	826,852
Last Close Price	4435.00	3785.00	4109.78	5461.80	7834.55	11550.36
PE Ratio	27.70	29.74	-	-	-	-
Forward PE	-	58.75	58.75	58.75	58.75	58.75
PS Ratio	2.18	1.86	1.96	3.32	3.14	4.84
PB Ratio	1.31	1.10	1.29	1.78	2.20	3.15
P/TBV Ratio	1.33	1.11	1.32	1.93	2.34	3.36
P/FCF Ratio	86.75	26.29	9.69	-	49.25	34.31
P/OCF Ratio	34.38	17.40	9.14	-	36.39	33.29
EV/Sales Ratio	1.54	1.18	1.75	2.93	2.72	4.53
EV/EBITDA Ratio	17.20	12.04	48.99	-	106.23	79.01
EV/EBIT Ratio	25.19	16.70	173.34	-	-	147.08
EV/FCF Ratio	61.28	16.65	8.65	-	42.67	32.12
Debt / Equity Ratio	0.24	0.24	0.33	0.34	0.00	0.01
Debt / EBITDA Ratio	4.49	4.09	13.88	-	0.19	0.15
Debt / FCF Ratio	15.99	5.66	2.45	-	0.08	0.06
Net Debt / Equity Ratio	-0.39	-0.40	-0.21	-0.31	-0.31	-0.29
Net Debt / EBITDA Ratio	-7.17	-6.91	-8.85	2.16	-17.31	-7.90
Net Debt / FCF Ratio	-25.53	-9.56	-1.56	5.89	-6.95	-3.21
Asset Turnover	0.48	0.47	0.40	0.30	0.48	0.46
Inventory Turnover	2.31	2.33	1.75	1.66	2.87	2.36
Quick Ratio	2.03	2.09	4.37	1.93	3.90	4.79
Current Ratio	2.55	2.57	5.76	2.61	4.90	5.95
Return on Equity (ROE)	4.75%	4.25%	-1.45%	-13.60%	-1.54%	-1.01%
Return on Assets (ROA)	1.82%	2.08%	0.25%	-5.65%	-0.04%	0.88%
Return on Invested Capital (ROIC)	5.98%	7.11%	0.91%	-21.45%	-0.12%	-2.07%
Return on Capital Employed (ROCE)	3.50%	4.00%	0.50%	-11.30%	-0.10%	1.60%
Earnings Yield	3.15%	3.36%	-0.84%	-7.50%	-0.41%	-0.10%
FCF Yield	1.15%	3.80%	10.32%	-2.92%	2.03%	2.92%
Payout Ratio	35.74%	39.28%	-	-	-	-
Buyback Yield / Dilution	-45.42%	-21.97%	1.06%	-	0.01%	0.25%